Randomized multicenter Phase II trial of two different schedules of irinotecan combined with capecitabine as first-line treatment in metastatic colorectal carcinoma

Emilio Bajetta; Maria Di Bartolomeo; Luigi Mariani; Antonio Cassata; Salvatore Artale; Sergio Frustaci; Graziella Pinotti; Andrea Bonetti; Ignazio Carreca; Guido Biasco; Luigi Bonaglia; Giovanni Marini; Antonio Iannelli; Diego Cortinovis; Ermina Ferrario; Elena Beretta; Antonio Lambiase; Roberto Buzzoni;

doi:10.1002/cncr.11910

Randomized multicenter Phase II trial of two different schedules of irinotecan combined with capecitabine as first-line treatment in metastatic colorectal carcinoma

Cancer ◽

10.1002/cncr.11910 ◽

2004 ◽

Vol 100 (2) ◽

pp. 279-287 ◽

Cited By ~ 107

Author(s):

Emilio Bajetta ◽

Maria Di Bartolomeo ◽

Luigi Mariani ◽

Antonio Cassata ◽

Salvatore Artale ◽

...

Keyword(s):

Colorectal Carcinoma ◽

Phase Ii ◽

Phase Ii Trial ◽

Line Treatment ◽

Metastatic Colorectal Carcinoma ◽

First Line ◽

Multicenter Phase ◽

First Line Treatment

Download Full-text

5.40 Rituximab Maintenance in Patients with Chronic Lymphocytic Leukemia after First-Line Treatment with Rituximab plus Fludarabine, Cyclophosphamide, and Mitoxantrone: Final Results of a Multicenter Phase II Trial on Behalf of the Spanish CLL Study Group (GELLC)

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/j.clml.2011.09.194 ◽

2011 ◽

Vol 11 ◽

pp. S270-S272

Author(s):

Francesc Bosch ◽

Pau Abrisqueta ◽

Neus Villamor ◽

María José Terol ◽

Eva González-Barca ◽

...

Keyword(s):

Chronic Lymphocytic Leukemia ◽

Phase Ii ◽

Phase Ii Trial ◽

Lymphocytic Leukemia ◽

Study Group ◽

Line Treatment ◽

First Line ◽

Rituximab Maintenance ◽

Multicenter Phase ◽

First Line Treatment

Download Full-text

First-line treatment of pancreatic cancer patients with the combination of 5-fluorouracil/folinic acid plus gemcitabine: a multicenter phase II trial by the CONKO-study group

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-011-1602-3 ◽

2011 ◽

Vol 68 (5) ◽

pp. 1173-1178 ◽

Cited By ~ 5

Author(s):

Uwe Pelzer ◽

Dirk Arnold ◽

Peter Reitzig ◽

Julia Herrenberger ◽

Friedrich Wilhelm Korsten ◽

...

Keyword(s):

Pancreatic Cancer ◽

Folinic Acid ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Trial ◽

Study Group ◽

Line Treatment ◽

First Line ◽

Multicenter Phase ◽

First Line Treatment

Download Full-text

LONG-TERM RESULTS OF THE MULTICENTER PHASE II TRIAL WITH BENDAMUSTINE AND RITUXIMAB AS FIRST LINE TREATMENT FOR PATIENTS WITH MALT LYMPHOMA (MALT-2008-01).

Hematological Oncology ◽

10.1002/hon.2437_137 ◽

2017 ◽

Vol 35 ◽

pp. 147-148 ◽

Cited By ~ 1

Author(s):

A. Salar ◽

E. Domingo-Domenech ◽

C. Panizo ◽

C. Nicolás ◽

J. Bargay ◽

...

Keyword(s):

Phase Ii ◽

Malt Lymphoma ◽

Phase Ii Trial ◽

Long Term Results ◽

Line Treatment ◽

First Line ◽

Multicenter Phase ◽

First Line Treatment

Download Full-text

Randomized Multicenter Phase II Trial of Oxaliplatin Plus Irinotecan Versus Raltitrexed as First-Line Treatment in Advanced Colorectal Cancer

Journal of Clinical Oncology ◽

10.1200/jco.20.1.165 ◽

2002 ◽

Vol 20 (1) ◽

pp. 165-172 ◽

Cited By ~ 22

Author(s):

W. Scheithauer

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Advanced Colorectal Cancer ◽

Phase Ii Trial ◽

Line Treatment ◽

First Line ◽

Multicenter Phase ◽

First Line Treatment

Download Full-text

345P Optimal dose of eribulin as first line treatment in elderly patients ≥ 70 years with advanced breast cancer: A multicenter phase II trial [SAKK 25/14]

Annals of Oncology ◽

10.1016/j.annonc.2020.08.447 ◽

2020 ◽

Vol 31 ◽

pp. S385

Author(s):

U. Hasler-Strub ◽

A. Mueller ◽

Q. Li ◽

B.J.K. Thuerlimann ◽

S. Gerber ◽

...

Keyword(s):

Breast Cancer ◽

Elderly Patients ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Optimal Dose ◽

Line Treatment ◽

First Line ◽

Multicenter Phase ◽

First Line Treatment

Download Full-text

Dasatinib First-Line Treatment in Gastrointestinal Stromal Tumors. a Multicenter Phase II Trial of the SAKK (SAKK 56/07)

Annals of Oncology ◽

10.1016/s0923-7534(20)34067-9 ◽

2012 ◽

Vol 23 ◽

pp. ix480

Author(s):

M. Montemurro ◽

J. Domont ◽

P. Rutkowski ◽

A.D. Roth ◽

R. von Moos ◽

...

Keyword(s):

Phase Ii ◽

Gastrointestinal Stromal Tumors ◽

Phase Ii Trial ◽

Line Treatment ◽

First Line ◽

Stromal Tumors ◽

Multicenter Phase ◽

First Line Treatment

Download Full-text

Carboplatin plus gemcitabine as first-line treatment in eldelry patients with non-small-cell lung cancer: Preliminary results of a multicenter phase ii trial by the Hellenic Oncology Researsch Group (HORG)

Journal of Geriatric Oncology ◽

10.1016/j.jgo.2013.09.039 ◽

2013 ◽

Vol 4 ◽

pp. S40

Author(s):

L. Vamvakas ◽

A. Karampeazis ◽

S. Agelaki ◽

N. Kentepozidis ◽

A. Polyzos ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

Multicenter Phase ◽

First Line Treatment

Download Full-text

Everolimus with paclitaxel and carboplatin as first-line treatment for metastatic large-cell neuroendocrine lung carcinoma: a multicenter phase II trial

Annals of Oncology ◽

10.1093/annonc/mdx268 ◽

2017 ◽

Vol 28 (8) ◽

pp. 1898-1902 ◽

Cited By ~ 23

Author(s):

P. Christopoulos ◽

W. Engel-Riedel ◽

C. Grohé ◽

C. Kropf-Sanchen ◽

J. von Pawel ◽

...

Keyword(s):

Phase Ii ◽

Lung Carcinoma ◽

Phase Ii Trial ◽

Large Cell ◽

Line Treatment ◽

First Line ◽

Multicenter Phase ◽

First Line Treatment

Download Full-text

1322 Cetuximab monotherapy and cetuximab plus capecitabine as first-line treatment in elderly patients with RAS- and BRAF wild-type metastatic colorectal cancer. Results of the multicenter phase II trial SAKK 41/10

European Journal of Cancer ◽

10.1016/s0959-8049(16)30565-2 ◽

2015 ◽

Vol 51 ◽

pp. S194-S195 ◽

Cited By ~ 1

Author(s):

D. Kienle ◽

R. Winterhalder ◽

D. Koeberle ◽

D. Horber ◽

M. Kueng ◽

...

Keyword(s):

Colorectal Cancer ◽

Elderly Patients ◽

Metastatic Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Line Treatment ◽

Wild Type ◽

First Line ◽

Multicenter Phase ◽

First Line Treatment

Download Full-text

A Multicenter Phase II Trial with Irinotecan plus Oxaliplatin as First-Line Treatment for Inoperable/Metastatic Cancer of the Biliary Tract

Oncology ◽

10.1159/000320462 ◽

2010 ◽

Vol 78 (5-6) ◽

pp. 356-360 ◽

Cited By ~ 11

Author(s):

Niki Karachaliou ◽

Aris Polyzos ◽

Nikolaos Kentepozidis ◽

Stylianos Kakolyris ◽

Nikolaos Ziras ◽

...

Keyword(s):

Biliary Tract ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Cancer ◽

Line Treatment ◽

First Line ◽

Multicenter Phase ◽

First Line Treatment

Download Full-text